Mathew Autterson is the Chief Executive Officer and President of CNS Bioscience Inc. Scott Falci founded the Company which he serves in in 2013. They deal in drug development with a particular focus on neuropathic pain.
Previously, Mr. Autterson had spent more than twenty-five years in financial services. He rose to positions of leadership and influence and acted as the president to a leading state chartered financial institution.
Mathew Autterson’s educational background
Mathew Autterson is a graduate of Michigan State University where he acquired his bachelor’s degree in Finance in 1980. He proceeded to further his education at the University of Denver Graduate Tax Program.
Upon completion, his career began at First Trust Corporation which was a subsidiary of Fiserv. In 1982, he left his job and joined a small group which chartered a new Colorado state chartered company. Fiserv later acquired the Resources Trust Company in 2001.
The present engagements of Mathew Autterson
Falci Adaptive Biosystems (FAB) has Mathew Autterson as one of its members in the team of board of directors. Mr. Autterson has also served on the board of Denver Zoo, the Web-Warring Foundation, and the Denver Zoological Foundation. He once acted as the chairman of the board of directors of Denver Hospice. Mathew Autterson was a member of the Worlds Presidents Organization and the Young Presidents Organization.
Thanks to his career commitments, Mathew Autterson has resided in different places in Colorado. He has lived in Greenwood Village, Eaglewood, Boulder, and Dever. Mr. Autterson possesses numerous skills such as wealth management both private and public and capital management consultation. Mr. Autterson has a blog, mathewautterson.com where he shares his experiences.
About Falci Adaptive Biosystems
This leading Biosystems Company has its headquarters in Englewood, Colorado. The company does not have any other branches outside the United States of America. The company was founded by Dr. Scott Falci, a chief neurosurgeon at Craig Hospital. The most recent sale of Falci Adaptive Biosystems is the Falci Adaptive Motorsport, a non-profit organization. The team does not trade stocks. The company has employed about ten people to assist in its operations.
The company’s management team and board of directors keep their focus in providing comprehensive and sophisticated patent strategies. Falci Adaptive motor systems make human machine interfaces and other cutting age technologies which assist people who are physically disabled.